Northern Trust Corp Inovio Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.35 - $0.53 $26,841 - $40,646	76,691 Added 16.01%	555,697 $283,000
Q3 2023 Nov 13, 2023	BUY	$0.38 - $0.58 $5,036 - $7,686	13,253 Added 2.85%	479,006 $186,000
Q2 2023 Aug 11, 2023	SELL	$0.39 - $0.94 $705,924 - $1.7 Million	-1,810,063 Reduced 79.53%	465,753 $209,000
Q1 2023 May 15, 2023	SELL	$0.79 - $1.91 $55,495 - $134,171	-70,247 Reduced 2.99%	2,275,816 $1.87 Million
Q4 2022 Feb 13, 2023	BUY	$1.41 - $2.5 $234,688 - $416,115	166,446 Added 7.64%	2,346,063 $3.66 Million
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $311,122 - $522,910	187,423 Added 9.41%	2,179,617 $3.76 Million
Q2 2022 Aug 12, 2022	BUY	$1.44 - $3.98 $144,499 - $399,381	100,347 Added 5.3%	1,992,194 $3.45 Million
Q1 2022 May 13, 2022	SELL	$2.97 - $5.2 $220,020 - $385,221	-74,081 Reduced 3.77%	1,891,847 $6.79 Million
Q4 2021 Feb 08, 2022	SELL	$4.99 - $7.46 $251,705 - $376,297	-50,442 Reduced 2.5%	1,965,928 $9.81 Million
Q3 2021 Nov 15, 2021	SELL	$7.16 - $9.69 $374,661 - $507,048	-52,327 Reduced 2.53%	2,016,370 $14.4 Million
Q2 2021 Aug 13, 2021	SELL	$6.23 - $10.03 $302,765 - $487,437	-48,598 Reduced 2.3%	2,068,697 $19.2 Million
Q1 2021 May 12, 2021	BUY	$8.81 - $16.96 $1.88 Million - $3.62 Million	213,599 Added 11.22%	2,117,295 $19.6 Million
Q4 2020 Feb 11, 2021	SELL	$8.5 - $12.85 $106,462 - $160,946	-12,525 Reduced 0.65%	1,903,696 $16.8 Million
Q3 2020 Nov 16, 2020	BUY	$9.57 - $27.05 $333,169 - $941,718	34,814 Added 1.85%	1,916,221 $22.2 Million
Q2 2020 Aug 14, 2020	BUY	$7.14 - $31.69 $4.75 Million - $21.1 Million	665,921 Added 54.79%	1,881,407 $50.7 Million
Q1 2020 May 14, 2020	BUY	$2.98 - $14.09 $502,711 - $2.38 Million	168,695 Added 16.12%	1,215,486 $9.04 Million
Q4 2019 Feb 14, 2020	SELL	$1.97 - $3.72 $210,626 - $397,731	-106,917 Reduced 9.27%	1,046,791 $3.46 Million
Q3 2019 Nov 13, 2019	BUY	$2.05 - $3.02 $236,676 - $348,665	115,452 Added 11.12%	1,153,708 $2.36 Million
Q2 2019 Aug 13, 2019	SELL	$2.29 - $4.1 $93,766 - $167,878	-40,946 Reduced 3.79%	1,038,256 $3.05 Million
Q1 2019 May 13, 2019	BUY	$3.34 - $5.1 $102,517 - $156,539	30,694 Added 2.93%	1,079,202 $4.03 Million
Q4 2018 Feb 12, 2019	BUY	$3.89 - $6.11 $41,887 - $65,792	10,768 Added 1.04%	1,048,508 $4.19 Million
Q3 2018 Nov 14, 2018	BUY	$3.92 - $5.58 $42,896 - $61,061	10,943 Added 1.07%	1,037,740 $5.77 Million
Q2 2018 Sep 18, 2018	SELL	$3.88 - $5.16 $21,922 - $29,154	-5,650 Reduced 0.55%	1,026,797 $4.03 Million
Q2 2018 Aug 14, 2018	BUY	$3.88 - $5.16 $152,115 - $202,297	39,205 Added 3.95%	1,032,447 $4.05 Million
Q1 2018 May 09, 2018	SELL	$4.05 - $5.69 $97,366 - $136,793	-24,041 Reduced 2.36%	993,242 $4.68 Million
Q4 2017 Feb 14, 2018	SELL	$4.13 - $6.68 $104,778 - $169,471	-25,370 Reduced 2.43%	1,017,283 $4.2 Million
Q3 2017 Nov 13, 2017	BUY	$5.36 - $6.37 $5.59 Million - $6.64 Million	1,042,653	1,042,653 $6.61 Million

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account